Reading time: 2 min Author Published on Updated on Weight loss Ready to transform your health
A refined study of FCRL genes from a genome-wide association study for Graves disease
MediVera compounds across 7 primary therapeutic categories: weight management (GLP-1 support compounds), hormone replacement therapy (HRT/BHRT), mens health (including testosterone replacement and ED support compounds), womens health, longevity and peptides, dermatology, and pet medications
Substance-use disorders Pre-clinical and mechanistic studies A large body of pre-clinical and mechanistic literature is available regarding the putative effects of GLP-1RAs on substance misuse (Supplementary Section 5): 24 for alcohol 59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82 , 8 for opiates 63,83,84,85,86,87,88,89 , 16 for stimulants, including cocaine and amphetamines 90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105 , and 4 for nicotine 106,107,108,109